Fate Therapeutics (FATE) Adds Two New VPs; Announces One Promotion
Tweet Send to a Friend
Fate Therapeutics (NASDAQ: FATE) announced that Wendy Levin, M.D., M.S. will join the Company as Vice President, Clinical Development and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE